EverythingALS, a nonprofit dedicated to accelerating research, technology, and patient access for amyotrophic lateral ...
There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association ...
Life could feel uncertain when you’re diagnosed with ALS. You wonder how your life will change, and how quickly. Time ...
A study showed cholesterol-lowering statins do not significantly affect ALS progression or survival. Statin prescriptions for ALS patients should be based on metabolic needs, not ALS diagnosis. More ...
A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Researchers have found that patients with amyotrophic lateral sclerosis have ...
ALS United Greater New York is accelerating progress in ALS research through continued investment and deepened national ...
Early initiation of tofersen (Qalsody) was associated with a numerically slower decline in people with SOD1 amyotrophic lateral sclerosis (ALS) compared with delayed treatment, according to data from ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. One of the most frustrating parts of amyotrophic lateral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results